you may be right about this. In reality, the history of
you may be right about this. In reality, the history of this stock price is written in violent moves up (and long drawn out declines). So if we do have a big positive catalyst, i agree there is the potential for a massive move in a short period of time.
so it really comes down to how quickly the hold is lifted. my biggest nagging concern on having the hold lifted is this:
The original hold inquiry was 5 tangible items i think. Cyrus laid them out, and actually kept us updated on the progress ("we've completed 3 of the 5", etc.). So we had a pretty black and white list of deliverables - which as far as i can understand, we delivered. The hold should then have been lifted - because the hold was based on 2 deaths and the concern they were tied our drug, and we proved they were not.
This second inquiry (i.e. wild goose chase) veered of the topic of safety - and to me seemed more amorphous - i'm not sure as an investor i ever saw the exact list of items? I know it included future plans for HIV, meetings with Key Opinion Leaders, etc. A lot of information was provided to the FDA - some seemingly subjective vs. objective (i.e. KOL feedback).
My point is - if the FDA didn't lift the safety-related hold when we clearly delivered 5 tangible items to show the drug's safety - what are the chances they simply lift the hold without further questions when the deliverables seemed so much more random, subjective and less concrete?
Hopefully - they look at the original submission (showing the drug is safe) and then say "ok, these guys did a lot of work - let's throw them a bone, because the hold should have been lifted already anyway". That would be the reasonable approach. But we're dealing with the FDA here - not the most reasonable group...
5
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Rethinking Beauty Industry's AI Obsession Here’s a breath of fresh air from the otherwise AI-obsessed beauty landscape: SACHEU, the brand that's been turning heads in cosmetics, decided to pair up with Limitless Labs. This partnership isn't about ceding control to machines but amplifying genuine human voices in their product development process. Yeah, it's a...
Continue Reading
Navigating the AI Maze: Flux's New Pathways Ever feel like these engineering platforms speak a language of their own? Flux's latest expansion finally offers a translator that matters. It's all about decoding whether your AI investment is delivering the goods. Engineering leaders now have more than just fluffy metrics; Flux breaks down real code-based evidence to show if...
Continue Reading
Navigating the healthcare maze isn't for the faint of heart, especially when it comes to making sure that dollars spent on food benefits actually translate to improved health. Enter Foodsmart, the foodcare powerhouse that just rolled out its Food-is-Medicine Benefits Management (FBM) program. Turning Meals into Measurable Metrics Health plans are under mounting pressure...
Continue Reading
Ever found a protein shake that tastes like a candy bar from the future? Well, Hi-Tech Pharmaceuticals is banking on their new Dubai Chocolate flavor to hit that sweet spot. This isn't your typical powdered shake game; Hi-Tech's been cranking the flavor dial ever since they introduced their Precision Protein® line back in 2016. They've carved out a niche with unique...
Continue Reading
Something's Buzzing at the Big Board Walk over to Wall Street on September 23rd, and guess what you get? A lot more than just stock tickers blinking away. First Lady Melania Trump’s stealing the show at the New York Stock Exchange to kick off the inaugural IMPERIA Summit. She’s there to sound the opening bell and lead the charge in a summit that's focused on the...
Continue Reading
Stepping Boldly into the Livestreaming Arena There's a new kid in the chaotic neighborhood of social media, and it's called GoLive Streamers. Not just another aimless stroll down Content Highway, GoLive is weaving its own defining path by fostering genuine real-time interaction. Launched in April 2026, this plucky platform has quickly amassed a following of over 74,000...
Continue Reading
Straight outta Burlington, the M&T Bank Vermont City Marathon is giving its course a facelift and, get this, throwing a half marathon into the mix for 2027. It's about time they shook things up, considering how this race is supposed to be one of the most welcoming on the block. I mean, you're talking about a marathon that's practically been the crown jewel of Vermont's...
Continue Reading
BlueCollar Cloud Aligns with SuiteWorld 2026 If you thought the construction ERP space was just a dusty office in a backlot, think again. BlueCollar Cloud is strapping on its boots and diving into the heart of SuiteWorld 2026 with a platinum sponsorship. This isn't just a walk in the park—it's a strategic power move, aligning themselves smack-dab in the middle of...
Continue Reading
Oracle Steps into Healthcare's Payment Arena You ever try solving a puzzle with half the pieces missing? Well, that's exactly what healthcare orgs have been doing with their revenue cycles. Oracle (NYSE:ORCL) thinks it’s got the missing pieces. They've announced some slick AI capabilities to grease the wheels of healthcare revenue management. But hey, I've seen grand...
Continue Reading
Greasezilla is shaking up the world of waste management, folks. With municipal sewer systems clogged by fats, oils, and grease, Greasezilla's no-nonsense approach is a breath of fresh air. They've just fired up their new regional hub in Ashland, Virginia, taking another hefty step towards easing this burden on municipalities. This ain't small potatoes—this national...
Continue Reading
Top 5 Most Recently Viewed Articles
Nvidia Faces Trade Challenges As a leading player in the semiconductor industry, Nvidia (NASDAQ: NVDA) is currently grappling with the complexities of international trade relations. The recent tensions between the United States and China have put the company under scrutiny, especially following accusations from Chinese regulators that suggest Nvidia may have violated...
Continue Reading
Analyzing REV Group Inc. Stock Performance Currently, REV Group Inc. (NYSE: REVG) has a stock price of $59.88, reflecting a slight dip of 0.75%. Despite this drop, the company has experienced an impressive increase of 7.10% over the past month, and a remarkable growth of 116.52% in the last year. This information sparks curiosity among investors regarding whether REVG is...
Continue Reading
InMode's Strategic Participation in Major Investor Conferences InMode Ltd. (NASDAQ: INMD) is setting the stage for greater visibility in the financial community through its engagement at several noteworthy investor conferences. As a prominent provider of cutting-edge medical technologies, the company aims to showcase its innovative advancements and build relationships...
Continue Reading
Power Nickel Inc Announces a Strategic Spin-Out Power Nickel Inc. is thrilled to announce an important strategic move for the company. They have executed an arrangement agreement to initiate the spin-out of their Golden Ivan property and several Chilean assets. This strategic reorganization is designed to enhance shareholder value by allowing for more focused development...
Continue Reading
GSMA M360 Eurasia Showcases AI and 5G Innovations Emphasizing the importance of inclusion and growth, this year's GSMA M360 Eurasia event places regional voices and underrepresented languages at the forefront of AI discussions. This significant gathering, drawing in policymakers, industry leaders, and visionaries, aims to delve into the transformative power of digital...
Continue Reading